Rogers S Y, Bradbury D, Kozlowski R, Russell N H
Department of Haematology, Nottingham City Hospital, UK.
Exp Hematol. 1994 Jul;22(7):593-8.
Blast cells from 70% of patients with acute myeloid leukemia (AML) show some evidence of in vitro autonomous growth, which appears to be related to the autocrine secretion of growth factors, particularly granulocyte-macrophage colony-stimulating factor (GM-CSF). In the majority of cases, the growth factors appear to be involved in classical extracellular autocrine or paracrine loops with neutralizing antibodies to the relevant cytokine inhibiting growth. In a minority, however, antibodies do not inhibit growth despite evidence of secretion of the cytokine. There is evidence for intracellular autocrine loops in murine leukemic cell lines. In this study, we wished to investigate for the presence of such intracellular loops involving GM-CSF in AML blast cells. Blast cells from 11 patients with AML were cultured in the presence of either neutralizing GM-CSF antibody or an antisense oligonucleotide directed against GM-CSF. We also studied the effect of the oligonucleotide on the autonomous growth of cells whose production of GM-CSF had been apparently abolished by either interleukin-1 receptor antagonist (IL-1Ra) or following blast cell purification using the CD34 antigen. The autonomous growth of the blast cells from nine of the 11 patients was inhibited by the antisense oligonucleotide (but not by the control sense oligonucleotide). However, only six of the nine were inhibited by the anti-GM-CSF antibody. Similarly, in one patient whose CD34 purified blast cells continued to show a high degree of autonomous growth but did not produce detectable GM-CSF, growth was inhibited by the antisense oligonucleotide but not by antibody, while in another patient whose cells were inhibited by IL-1Ra with, again, loss of detectable GM-CSF, growth could be further inhibited by the addition of the oligonucleotide but not the antibody. These studies provide evidence that intracellular autocrine loops involving GM-CSF are involved in the autonomous growth of some AML blast cells.
70%的急性髓系白血病(AML)患者的原始细胞显示出一些体外自主生长的迹象,这似乎与生长因子的自分泌有关,尤其是粒细胞-巨噬细胞集落刺激因子(GM-CSF)。在大多数情况下,生长因子似乎参与了经典的细胞外自分泌或旁分泌循环,针对相关细胞因子的中和抗体可抑制生长。然而,在少数情况下,尽管有细胞因子分泌的证据,但抗体并不能抑制生长。在小鼠白血病细胞系中有细胞内自分泌循环的证据。在本研究中,我们希望研究AML原始细胞中是否存在涉及GM-CSF的此类细胞内循环。将11例AML患者的原始细胞在存在中和GM-CSF抗体或针对GM-CSF的反义寡核苷酸的情况下进行培养。我们还研究了该寡核苷酸对GM-CSF产生已被白细胞介素-1受体拮抗剂(IL-1Ra)或使用CD34抗原进行原始细胞纯化后明显消除的细胞自主生长的影响。11例患者中有9例的原始细胞自主生长被反义寡核苷酸抑制(但未被对照正义寡核苷酸抑制)。然而,这9例中只有6例被抗GM-CSF抗体抑制。同样,在1例患者中,其CD34纯化的原始细胞继续显示出高度的自主生长,但未产生可检测到的GM-CSF,生长被反义寡核苷酸抑制但未被抗体抑制,而在另1例患者中,其细胞被IL-1Ra抑制,同样未检测到GM-CSF,添加寡核苷酸可进一步抑制生长,但抗体则不能。这些研究提供了证据,表明涉及GM-CSF的细胞内自分泌循环参与了一些AML原始细胞的自主生长。